26th Annual Biotech in Europe Forum

FOR GLOBAL PARTNERING & INVESTMENT

7th - 8th of October 2026|MÖVENPICK HOTEL BASEL | SWITZERLAND

Attendees:

+ND Capital

3B Future Health Fund

3i Group plc

6465 Therapeutics

AATec Medical GmbH

AbbVie Ventures

AbbVie, Inc.

abcDNA GmbH

Abivax SA

Accequa

AdBio Partners

AdCab

ADOCIA

Adularia AG

Advantary Capital Partners

AEC Partners

AFK & Partners Asset Management LLC

Akribion Therapeutics GmbH

Alchemab Therapeutics Ltd

Alipheron AG

Allegro N.V.

Alphion UG

Alternative Assets Finance

Alzinova AB

Ampleia

Amplio Pharma

Amporin Pharmaceuticals AG

AMR Action Fund GP GmbH

Anaka Pharmaceuticals, Inc.

Anaveon AG

Andera Partners SA

Angelini Ventures S.p.A.

Anima Biotech Inc.

Apollo Health Ventures

ARCHIMED

Argenx

Argobio Studio

Asahi Kasei Europe GmbH

Asian Innovation & Finance Center (AIFC)

Asklepios Advisors

Astellas Pharma Europe Ltd.

Astr Partners

AstraZeneca

Astrivax Therapeutics N.V.

ATGN Consulting

Atlas Capital Ventures LLC

AudioCure Pharma GmbH

Aukera Therapeutics AG

AurorA Science Srl

Avance Life Sciences

Awen GmbH

Baker McKenzie

BaseLaunch

Bayern Kapital GmbH

BB Biotech AG

Beneficious LLC

BeOne Medicines I GmbH

Bergaud & Partners

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

Biodelphis Therapeutics SA

BioMedPartners AG

BiomedVC AG

BioPharma Advisory

Biopôle SA

Bioqube Ventures

BIOSTART Consulting GmbH

biotx.ai GmbH

Biovance Capital

Biovision Ventures

Bioxodes SA

BlackRock

Blackstone Group

Bloomberg Intelligence

Bloomberg LP

BNP Paribas Asset Management

Boehringer Ingelheim International GmbH

Boehringer Ingelheim Venture Fund GmbH

BOHE Angel Fund

Borea Therapeutics S.r.l.

Bpifrance

Brainomix Limited

Brandon Capital Partners

Breakline Resolution

Brenus Pharma

Breslin AG

BSM Biotech Holding GmbH

Business Angels Switzerland

Caedo Oncology AS

Caladrix Pty Ltd

Cancer Research and Biotechnology AG

Cancer Research Horizons

Canton of Basel-Stadt

Capital Grand Est

CARTemis Therapeutics GmbH

Cati Therapeutics

CB Therapeutics

CD4 Therapeutics GmbH

CDP Venture Capital SGR ​S.p.A.

CDR-Life, Inc.

CellProthera SAS

Cereus Biosciences

CheckBrain Therapeutics

Chugai Venture Fund, LLC

Claris Ventures

ClearideBio Therapeutics AG

Cohesion Bureau

Connext Co., Ltd.

Convergence Partners

Convert Pharmaceuticals SA

Corinthian Financial Management Ltd

Coulter Partners

Covington & Burling LLP

CPTx GmbH

CureGBM

Curlim

DeBere Partners Limited

Debiopharm International SA

DeepTech & Climate Fonds

Dementia Discovery Fund 2 L.P. (SV Health Investors)

Diamante Società Benefit Srl

Digital Networks PLC

docdok.health Ltd.

Earlybird Health Management GmbH & Co. KG

École polytechnique fédérale de Lausanne (EPFL)

Eight Bridges

Eli Lilly and Company

Ennovate Pharma

Ervimmune

ESC Advisors

European Braintech Fund

European Investment Bank

European Investment Fund

Evernow Publishing Ltd, publisher of MedNous

Evidenze

Evotec AG

Expert Systems, Inc.

ExpreS2ion Biotech Holding AB

F. Hoffmann-La Roche AG

FimmCyte AG

Finanz und Wirtschaft

FINNCURE Ltd.

FluoSphera SA

Fontaine Capital

Forbion

Forta Bio, Inc.

Fortlane Partners GmbH

Forty51 Ventures AG

Forvis Mazars

FoRx Therapeutics AG

Fraser Partners

FreeMind Group

Fresenius Ventures

Fund+

Futurewave AG

Galimedix Therapeutics, Inc.

Generation Fund Life Sciences Fund I

Genevant Sciences GmbH

Genius Search GmbH & Co. KG

Genmab A/S

Gero Pte. Ltd

Gibela Therapeutics GmbH

GIBF

Gilde Healthcare Partners BV

Gimv

GlobalClose Alliances (GCA)

GOLDTRACK Ventures GmbH

GreenBone Ortho S.p.A.

GSK

Gubra Ventures

Gyre Therapeutics, Inc.

Hadean Ventures

Hansa Biopharma AB

Health Innovation Capital

HealthCap

HeartBeat.bio AG

Helsinn Healthcare SA

HEPHAISTOS-Pharma

HGF Limited

High-Tech Gründerfonds Management GmbH

HiRO

HK WinHealth Pharma Group

Hong Kong Economic and Trade Office, Berlin (HKETO)

Hong Kong Exchanges and Clearing Limited (HKEX)

Hong Kong Trade Development Council

HOX Therapeutics Ltd.

i&i Biotech Fund I SCSp

IAG, Image Analysis Group

IAMA Therapeutics S.r.l.

ICF Consult Switzerland

ICOSA Group

Immunethep, S.A.

Indaco Venture Partners SGR S.p.A.

Industrifonden

InflaRx GmbH

iniuva GmbH

Innovestor Life Science Ltd.

Innunity Therapeutics

INOGROUP GmbH

Institute of Molecular & Clinical Ophthalmology Basel (IOB)

Intercontinental Capital

Intermediate Capital Group PLC

Inveready Asset Management S.G.E.I.C., S.A.

InvestHK

IPF Partners

iQure Pharma Inc.

IQVIA

Italian Angels for Growth (IAG)

IXICO plc

J.P. Morgan

Jeito Capital

JFG Life Sciences Stiftung der Universität Basel

Johnson & Johnson Innovation LLC

JT Advisory

Justin Stindt Consulting AG

Kerna Ventures

kez.biosolutions GmbH

KG Capital Management LLC.

KHAN Fund

Kinled Holding Limited

Kondree

KPMG Paris

KreaMedica Holdings Inc.

Ksilink

Kurma Partners

Landmark BioVentures AG

Laverock Therapeutics Ltd.

Leads To Development SAS

LifeArc Ventures

LifeCare Partners GmbH

Lifespan Vision Ventures LLC

LIMAA Technologies GmbH

LMU Munich

Loma Therapeutics

Lonza Group AG

Lucera GmbH

Lynx Financial Hong Kong Ltd.

Mabqi S.A.S.

Maeve Therapeutics B.V.

MARATHON Beteiligungs AG

MC Services AG

Meddenovo Drug Design SAS

Medicxi

MedinCell S.A.

MEDiSTRAVA

Meliodays Medical GmbH

Merck KGaA

Mérieux Equity Partners

Metaimmune Therapeutics

Micreos Pharma

MIG Capital AG

Mirabaud & Cie SA

Modi Ventures

MONCYTE Health

Move Venture Consulting

MultivisionDx

Mwyngil Therapeutics

Myria Biosciences AG

Nanolynx Biologics AG

NatIgGs GmbH

Neolie Science Partners

Nerai Bioscience AG

Neumirna Therapeutics ApS

Neurimmune AG

NeutroGen Therapeutics GmbH

New Science Fund

Nextech

NG Bio LTD

Nœtica Pharma

Nomal Therapeutics

Novac BiotechBD

Novartis BioMedical Research

Novartis Oncology

Novartis Pharma AG

Novartis Venture Fund

Novateur Ventures Inc

Novo Holdings A/S

Novo Nordisk A/S

NRW.Venture

NRx Pharmaceuticals, Inc.

NS Pharma, Inc.

Nucleome Therapeutics Ltd.

Nucleus Network Ltd

NXI Therapeutics AG

NxR Biotechnologies GmbH

O11 biomedical GmbH

OGD2 Pharma

OKG Capital LP

Okomera

Omega Funds

Oncode Accelerator

Oncostellae

One04 Therapeutics

Oppenheimer & Co. Inc.

Organon

Origenis GmbH

Otsuka Pharmaceutical Europe Ltd.

Oxford Science Enterprises plc

OxSonics

Panakès Partners SGR SpA

Panosome GmbH

Parexel International

Partners Group

Peppermint VenturePartners GmbH

Peregrine Ventures

Perseo Pharma AG

Persica Pharmaceuticals Limited

PharmCube

PharmNovo AB

Playground Global

Procavea Biotech AG

PSCC

PulseSight Therapeutics SAS

PureDEL

Pureos Bioventures

QUASAR Therapeutics GmbH

Rahim Invest SÀRL

Real Web SA Luxembourg

Reconnect Labs AG

Recordati Pharma GmbH

Redalpine Venture Partners AG

Rhea BioVentures

Roche Venture Fund

Ropes & Gray LLP

RV Invest GmbH

Salus Partners SA

Sappiens SAS

Schwarz Financial Communication

SCI Ventures LLC

Secarna Pharmaceuticals GmbH & Co. KG

SEDGE Ventures LLC

Seekyo Therapeutics

Selonterra, Inc.

SEQENS

Serca Pharmaceuticals AS

Serenatis Bio Ltd.

Servier Ventures

Seventure Partners

Shanda Grab Ventures Limited

Sirona Capital

Skyvor Medical AG

Sobi

Sofinnova Partners

Solgate GmbH

SPARK Finland

SpliceBio, S.L.

Sprim Global Investments

Staatz BD & Strategy

StemInov SAS

Stifel

Strategic Transactions Advisory AG

Strike Pharma AB

Sunstone Life Science Ventures

Superlab Suisse AG

Swiss Biotech Association

SWISS IMMUNE | SWISS Orphan EDC AG

Switchkine SA

SymphoRNA

SynAct Pharma

Synameta Therapeutics

T-CURX GmbH

T-Therapeutics Ltd.

TargImmune Therapeutics AG

Teitur Trophics ApS

Terra Quantum AG

TFS HealthScience

The Fulford Group Ltd.

Therakles Pharmaceuticals AG

TheraVenture GmbH

Tigermed

TiltBio Inc.

TMA

TOLREMO Therapeutics AG

Tribune Therapeutics AB

Tridek-One Therapeutics

Truffle Capital

Tuari Therapeutics GmbH

TVM Capital Life Science

UBS AG

UCB Ventures

UI Investissement

Umlaut.bio GmbH

Unison Innovations

Universite Paris-Saclay

University of Zurich

UPyTher B.V.

UZH Life Sciences Fund, AG

VALANX Biotech GmbH

Valink Therapeutics

Valor Management

VBW Holdings, LLC

Venture Valuation VV AG

Versant Ventures

Vesalius Biocapital IV Partners SàRL

Vi Partners AG

Viopas Venture Consulting GmbH

Vogel BioC

VS Principal Investments AG

VU Venture Partners

VUS Genetics

Wellington Partners

WG Partners LLP

WuXi AppTec

XGEN Venture SGR S.p.A.

Xlife Sciences AG

XOventure

YAYA Capital

YGION Biomedical GmbH

Ysios Capital

Zinc VC

ZZZ Sachs Testin

Last updated: October 6, 2026

SACHS ASSOCIATES SWITZERLAND AG

Aeschenvorstadt 4
Basel | CH-4051
Switzerland

SACHS ASSOCIATES LTD.

3rd floor, 89-90 Paul Street
London | EC2A 4NE
United Kingdom
Privacy Policy

© COPYRIGHT 2026. ALL RIGHTS RESERVED.